Filing Details
- Accession Number:
- 0001615774-17-007619
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-27 14:04:32
- Reporting Period:
- 2017-12-26
- Accepted Time:
- 2017-12-27 14:04:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | Pharmaceutical Preparations (2834) | 261434750 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563420 | Seth Lederman | C/O Tonix Pharmaceuticals Holding Corp 509 Madison Ave., Suite 306 New York NY 10022 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2017-12-26 | 5,300 | $3.61 | 22,700 | No | 4 | P | Indirect | By 401(k) plan |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By 401(k) plan |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.001 Par Value | 45,900 | Indirect | By IRA account |
Common Stock, $0.001 Par Value | 11,166 | Direct | |
Common Stock, $0.001 Par Value | 3,100 | Indirect | By spouse |
Common Stock, $0.001 Par Value | 2,917 | Indirect | By Leder Laboratories, Inc. |
Common Stock, $0.001 Par Value | 2,917 | Indirect | By Starling Pharmaceuticals, Inc. |
Common Stock, $0.001 Par Value | 18,463 | Indirect | By Lederman & Co., LLC |
Common Stock, $0.001 Par Value | 3,246 | Indirect | By L&L Technologies, LLC |
Common Stock, $0.001 Par Value | 5,898 | Indirect | By Targent Pharmaceuticals, LLC |
Footnotes
- The volume weighted average purchase price of common stock purchased by the reporting person in open market transactions on the transaction date. The range of purchase prices on the transaction date was $3.5834 to $3.619 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
- Reporting person may be deemed to be a control person of this entity.